Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation.
about
Pepper mild mottle virus, a plant virus associated with specific immune responses, Fever, abdominal pains, and pruritus in humansPlant Viruses as Nanoparticle-Based Vaccines and AdjuvantsCrystal Structure of the Coat Protein of the Flexible Filamentous Papaya Mosaic VirusEngineering of papaya mosaic virus (PapMV) nanoparticles through fusion of the HA11 peptide to several putative surface-exposed sitesImprovement of the trivalent inactivated flu vaccine using PapMV nanoparticlesPlant virus expression vector development: new perspectives.Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivoHuman metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling.Can plant viruses cross the kingdom border and be pathogenic to humans?A novel M2e based flu vaccine formulation for dogs.To investigate the necessity of STRA6 upregulation in T cells during T cell immune responses.Mouse liver-specific CD8(+) T-cells encounter their cognate antigen and acquire capacity to destroy target hepatocytes.Feasibility of Cowpea chlorotic mottle virus-like particles as scaffold for epitope presentations.Efnb1 and Efnb2 proteins regulate thymocyte development, peripheral T cell differentiation, and antiviral immune responses and are essential for interleukin-6 (IL-6) signaling.Immune response to a potyvirus with exposed amino groups available for chemical conjugation.Virus-like particle-induced protection against MRSA pneumonia is dependent on IL-13 and enhancement of phagocyte function.Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivoA virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose.Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.Armc5 deletion causes developmental defects and compromises T-cell immune responses.In planta production of plant-derived and non-plant-derived adjuvants.Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP.Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells.Reconceptualizing cancer immunotherapy based on plant production systems.Complement Component 3 Regulates IFN-α Production by Plasmacytoid Dendritic Cells following TLR7 Activation by a Plant Virus-like Nanoparticle.Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses.Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway.Efficacy of a Virus-Like Nanoparticle As Treatment for a Chronic Viral Infection Is Hindered by IRAK1 Regulation and Antibody Interference.Repurposing Plant Virus Nanoparticles.Plant Virus Expression Vectors: A Powerhouse for Global Health.
P2860
Q21091139-68C6EF15-E855-49A4-B289-36418F10AF6EQ26782569-278F6A2D-1F86-489C-B43D-24F31AF15B49Q27679448-8E76A3A5-AE72-4209-9ECF-80E3F60C2476Q28731876-CBBC1BB9-EDE9-40F9-B0C7-8A64223B02A0Q28743086-4700463A-8750-4ED5-A0C7-D025B85FFAF3Q30361514-CF198988-AE31-43A9-AA7C-04D72456BBA5Q33517131-8D30027B-6981-4AEF-973A-E7A7FD3AF6E3Q33887642-EDCCC249-CDCC-4E7F-AACA-1080218127A1Q33916892-A2A2C517-F7CB-4A40-B836-7931F45D6A80Q34473239-1CEEA9EE-40DE-4C1B-99D2-93129AD1E076Q35009732-B4B522D8-D084-47DD-9D50-2A6D7CB0A06FQ35082352-B5E609D3-2C3D-4B1C-9390-7C5FF53C9A9BQ35737929-8A376651-D047-48DA-B108-4BAF64B6D752Q35756792-C29F7E18-5D36-4DDB-951F-51D08BFDC1F5Q35842060-3F3BDD7B-87B9-439E-BE05-7B42385D383AQ35984242-78651E62-CB16-4CE6-97DE-4FDFC448731CQ36071784-86F6AC24-02F3-4BC5-8E84-CC30FBBDF690Q36267811-6639E420-FD26-4511-AD32-937FFFEB16AEQ36630332-33A96FE0-FFD2-4900-A2C0-9F38F9D2FE30Q37077649-E26B1963-0DD8-457B-880F-2266A79F6C17Q37642446-E0E2E060-C966-45D0-B5F4-94542E20BEA7Q37776716-05B9C118-CFA9-4F15-805B-2411692B22E7Q37792984-0D0079B6-F08A-4DC1-AA01-E8B61E06FE53Q39709538-9CE1269A-B439-4215-83ED-BC928236D7D1Q39751992-5A29BD40-41B5-4220-8299-D191ACA9D635Q40051873-A8CF7E56-59AA-4C3F-8100-C67D067C14D5Q40444704-7FDA36A0-AA02-410B-B329-B502CE139BCEQ40700979-0696607E-24BE-4B38-B914-1517504709DAQ45369927-9AC402C6-8788-4744-B936-207C9B21B983Q47550781-CEB84613-44E8-4DEF-8A8E-022251C637C4Q50002181-A1F2DD4C-B85C-4411-9A86-06DDDD4D6C43Q50864889-0E4DB5F4-B711-4ACA-8E85-F8C2BC60A986
P2860
Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Novel plant virus-based vaccin ...... ugh dendritic cell maturation.
@ast
Novel plant virus-based vaccin ...... ugh dendritic cell maturation.
@en
type
label
Novel plant virus-based vaccin ...... ugh dendritic cell maturation.
@ast
Novel plant virus-based vaccin ...... ugh dendritic cell maturation.
@en
prefLabel
Novel plant virus-based vaccin ...... ugh dendritic cell maturation.
@ast
Novel plant virus-based vaccin ...... ugh dendritic cell maturation.
@en
P2093
P2860
P356
P1433
P1476
Novel plant virus-based vaccin ...... ugh dendritic cell maturation.
@en
P2093
Alain Lamarre
Denis Leclerc
Jérôme Denis
Patrick Lacasse
Réjean Lapointe
P2860
P304
P356
10.1128/JVI.01811-07
P407
P577
2007-11-07T00:00:00Z